Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients

Clinical trial NCT06572553 · UNKNOWN

Trial details

NCT number: NCT06572553
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Age-Related Macular Degeneration Diabetic Macular Edema Retinal Vein Occlusion

Start date: 2024-03-01
Primary completion: 2024-08-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.